SynthesisCardiovascular and interventional radiology2022
Endovascular Stenting in Superior Vena Cava Syndrome: A Systematic Review and Meta-analysis.
Synthesis in Cardiovascular and interventional radiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 34 citations in OpenAlex.
- Covered Endovascular Reconstruction of the Anonymous Confluence (CERAC): a technical note describing a confluence-preserving endovascular technique.CVIR endovascular · 2026Article
- Transcatheter Management of Congenital and Acquired Venous Lesions in Children.Journal of clinical medicine · 2026Article
- Contemporary management of superior vena cava syndrome.Journal of vascular surgery. Venous and lymphatic disorders · 2026Review
- Article
- Acute superior vena cava collapse after thymic carcinoma resection and failed pericardial bypass rescued by endovascular stenting: a case report.BMC surgery · 2026Article
- Article
- Review
- Superior vena cava-to-inferior vena cava bridging stent technique for cavo-atrial junction stenosis: a case series.European heart journal. Case reports · 2026Article
- Large-bore catheter selection in endovascular management of superior vena cava syndrome.Journal of vascular surgery cases and innovative techniques · 2025Article
- A Retrospective Analysis of Endovascular Stent Insertion for Malignant Superior Vena Cava Obstruction, Focusing on Anticoagulation Practices.Current oncology (Toronto, Ont.) · 2025Article
- Superior vena cava (SVC) stent placement in children and young adults with congenitally normal cardiac and caval anatomy.Pediatric radiology · 2025Article
- Intermittent Echocardiographic Monitoring During Superior Vena Cava Recanalization: A Protocol for Early Recognition and Management of Hemopericardium.CVIR endovascular · 2025Article
- Percutaneous stenting as treatment for chylothorax from superior vena cava syndrome: A case report.SAGE open medical case reports · 2025Article
- Inferior and Superior Vena Cava Reconstruction.Cardiovascular and interventional radiology · 2024Review
- Surgical resection of an intraluminal tumor in the azygos vein with an unknown primary site causing superior vena cava syndrome.Thoracic cancer · 2024Article
- Superior vena cava obstruction and cardiovascular implantable electronic devices-a new era of leadless devices.Mediastinum (Hong Kong, China) · 2024Review
- Management with right atrium to jugular and brachiocephalic vein bypass for dialysis catheter-related superior vena cava syndrome.Journal of vascular surgery cases and innovative techniques · 2023Article
- Acute Oncologic Complications: Clinical-Therapeutic Management in Critical Care and Emergency Departments.Current oncology (Toronto, Ont.) · 2023Review
- Invited Commentary: Endovascular Stenting in Superior Vena Cava Syndrome-A Systematic Review and Meta-analysis by Aung et al.Cardiovascular and interventional radiology · 2022Article
Corrections and comments
- Commented on by
- Commented on by
Authors and funding
5 authors at 4 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeEndovascular stenting has been used to manage superior vena cava syndrome for several decades and has become standard firstline practice. This study aims to investigate the outcomes of endovascular stenting in the management of superior vena cava syndrome (SVCS).
methodsMEDLINE, EMBASE and PUBMED online databases were searched, with studies involving more than ten adult patients included. Studies identified spanned 27 years, from 1993 to 2020. Meta-analyses were performed based on Clopper-Pearson estimation.
resultsFifty-four studies were identified, for a total of 2249 patients, of which 2015 had malignant SVCS and 222 benign SVCS. Pooled technical success and clinical success rates were 96.8% (95% CI 96.0-97.5%) and 92.8% (95% CI 91.7-93.8%). Technical success and clinical success rates for studies investigating benign SVCS alone were identical at 88.8% (95% CI 83.0-93.1%). Pooled patency remained above 90% for the first year. Average complication and re-intervention rates were 5.78% (SD = 9.3182) and 9.11% (SD = 11.190).
conclusionsThis review confirms the effectiveness of endovascular stenting in managing SVCS. Further directions of research may include specific outcomes of endovascular stenting in benign SVCS, and the impact of procedural characteristics, such as the use of anticoagulation and type of stent used, on outcomes. LEVEL OF EVIDENCE: Level III, systematic review of retrospective cohort studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.